Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy.

Movement disorders : official journal of the Movement Disorder Society - 1 May 1995

Planté-Bordeneuve V, Bandmann O, Wenning G, Quinn N P, Daniel S E, Harding A E

Abstract excerpt

Molecular genetic studies of the cytochrome P450 system enzyme CYP2D6, which hydroxylates debrisoquine, have indicated an excess of mutant alleles in large series of patients with Parkinson's disease (PD) when compared with controls. We have investigated CYP2D6 polymorphism in 91 patients with multiple system atrophy (MSA) in order to determine if this finding is specific to PD or if there is similar evidence of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Cytochrome P-450 Enzyme System

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to DNA Mutational Analysis

Share to Gene Expression

Share to Gene Frequency

Share to Genotype

Share to Mixed Function Oxygenases

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 7651442
DOI: 10.1002/mds.870100307

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy.PMID 7651442Read ↗

Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease.Semantic proximity Read ↗

Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease.Semantic proximity Read ↗

Mutant debrisoquine hydroxylation genes in Parkinson's disease.Semantic proximity Read ↗

Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's disease.Semantic proximity Read ↗

An association study of debrisoquine hydroxylase (CYP2D6) polymorphisms in schizophrenia.Semantic proximity Read ↗

Case-control study of debrisoquine 4-hydroxylase, N-acetyltransferase 2, and apolipoprotein E gene polymorphisms in Parkinson's disease.Semantic proximity Read ↗

Pharmacogenetics of Debrisoquine and its Use as a Marker For CYP2D6 Hydroxylation CapacitySemantic proximity Read ↗

Mutation frequencies of the cytochrome CYP2D6 gene in Parkinson disease patients and in families.Semantic proximity Read ↗

No association between schizophrenia and polymorphisms within the genes for debrisoquine 4-hydroxylase (CYP2D6) and the dopamine transporter (DAT).Semantic proximity Read ↗

Lack of association between debrisoquine 4-hydroxylase (CYP2D6) gene polymorphisms and schizophrenia.Semantic proximity Read ↗

Genetic polymorphism and Parkinson's disease in Taiwan: study of debrisoquine 4-hydroxylase (CYP2D6).Semantic proximity Read ↗

CYP2D6 allelic frequencies in young-onset Parkinson's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.